#Cancer_Immunology TME

A look into the Tumor Micro Environment (TME).
1/ There is a complex set of interactions that must go on between a tumor and its surroundings. It has to interact with the tissue cells, it needs nutrients, it needs oxygen, it needs to survive and proliferate in a hostile environment.
2/ One of the many things it has to achieve to exist and thrive is to overcome the immune system and its natural ability to find, target and destroy tumors. There are 3 key cells in the immune system that are designed to find and kill cells that are infected or defective.
3/ They are the Natural Killer (NK) cell, the Cytotoxic T cells, and the Macrophage. The NK cells deploy a set of damage receptors called Damage Associated Molecular Patterns (DAMPs) that recognize stressed cells. This can be things like Mic-a or Mic-b.
4/ Normal cells will express MHC I on their surface that tells the immune system they are healthy. These MHC I receptors are made up of an alpha chain and a beta chain.
5/ Defective cells will often display just 1 chain called MIC-a for the MHC I Chain related alpha chain or MIC-b for the MHC I Chain related beta chain. This is just one of the many ways NK cells can recognize an unhealthy cancer cell.
6/ The Cytotoxic T cells can detect Tumor Associated Antigens (TAA) which are just mutated versions of the normal self proteins. This can cause T cell activation and a cell mediated response. The Cytotoxic T cells will bind to and kill tumor cells that display their antigen.
7/ The last cells that are key are the Antigen Presenting Cells (APCs) like the Dendritic cells and Macrophage. The tumor not only competes with the healthy tissue for survival, but the cancer cells will battle each other in a survival of the fittest.
8/ There is a lot of cell death going on in the tumor. This naturally allows APCs like the Macrophage to clean up these dead cells and process TAA antigens. They can present these antigens to the T cells to activate a response.
9/ One of the hallmarks of tumor progression is the tumor evolves mechanism to evade the immune response. There are multiple ways the tumor will evade or redirect the immune system.
10/ The most common is the tumor cells will release signals that will recruit T regulatory cells and Myeloid Derived Suppressor Cells (MDSC) to the tumor which will promote tolerance by releasing signals that inactivate the immune cells like T cells and APCs.
11/ This is one of these hardest effects to overcome in the tumor microenvironment. One effective way to clear all these cells is the use of a lymphodepletion regiment like Flu/Cy. This works in cell therapies to clear the battle field.
12/ The next mechanism the tumor cells will deploy is the expression of immune cell suppressing receptors like PD-1, CTLA-4 and CD-47. These will engage with T cells and Macrophages and inhibit them from cell killing. We call them checkpoints as they stop the immune response.
13/ There is a huge amount of development going on to understand all the interactions between the immune cells and the tumor. There has been some great success with PD-1 and CTLA-4 and a lot of disappointments along the way trying to develop checkpoint inhibitors.
14/ Some of the early developing checkpoints are LAG-3, TIM-3, TIGIT and CD47. All of these are natural receptors used by healthy cells to block the immune system from killing any healthy tissues like with PD-1.
15/ The problem is the Tumor cells mutate to exploit this system to block the immune system and protect the tumor cells.
16/ The critical role of the immune system in protecting us from cancer has been well established by following patients who are immune suppressed from cancer treatments or organ transplants.
17/ Immune compromised patients have a significant risk for cancer. Even HIV patients will have higher risk of cancer related to the immune suppression of the virus. Some cancer patients get secondary cancers while their immune systems are suppressed from chemotherapy.
18/ The role of the immune system in oncology is now well established. The many interactions that play a role in cancer surviving in a healthy immune system is still developing.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Biotech2k

Biotech2k Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @Biotech2k1

15 Sep
My Game Plan:

Pathways:
$BPMC 3.37% core position
$MRTX 3.37% core position
$TPTX 3.37% core position
$SDGR 1.35%
$RVMD 2.7%
$RLAY 2.7%
$ERAS 0% considering but way too expensive
$RPTX 2.02%
$KNTE sold out as it was my weakest link
Protein Degraders:
$ARVN 1.35%
$KYMR 1.35% paying down a core position
$CCCC 2.02% paying down a core position
$GLUE 1.35% paying down a core position
CRISPR/Old Antibodies
$CRBU 1.35% paying down a core position
$BCAB 2.7% will sell out when I think its good opportunity.

CRISPR is way to crazy on values to waste money on here. It will implode someday, and I will be waiting.
Read 6 tweets
15 Sep
#Targeted_Protein_Degradation

A look into protein degraders.
1/ There are 2 types of protein degraders in development and a 3rd in concept phase of development. The first is the monoDAC, the second is the biDAC and the last is the triDAC.
2/ The monoDAC will bind with a covalent chemical bonding to the E3 ligase and alter its targeted function. It changes the shape of the E3 and directs it to place the ubiquitin molecule onto a protein it directs.
Read 7 tweets
15 Sep
#The_Proteasome

I look at how the Proteasome works.
1/ The Proteasome is a cellular organelle. Its like the recycling bin for proteins. When a cell is done with a protein, it tags it for destruction in the process called ubiquitination.
2/ The proteasome will load these tagged proteins and break them down into peptides of about 7 to 10 amino acids in length for recycling. They will further be broken down after into single amino acids for reuse to build new proteins.
Read 7 tweets
15 Sep
#Ubiquitination

A look at ubiquitination.
1/ Cells make, regulate and break down proteins constantly. They have a system to control the regulation of the proteins they produce. This is to remove unwanted proteins when no longer used.
2/ It also maintains healthy proteins as they degrade slowly over time. The process of ubiquitination is the tagging of these proteins by the cell for destruction. There are 3 enzymes that work in the process of ubiquitination.
Read 10 tweets
14 Sep
Looking at Protein Degraders:

Looking at the pathway coverage of the deragers.
1/ $ARVN
AR - Androgen receptor
ER - Estrogen receptor
BCL6 - transcription factor
KRAS - MAPK pathway
MYC - transcription factor
Tau - CNS
2/ $KYMR
IRAK4 - Inflammation pathway
STAT3 - cytokine receptor
Read 5 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(